Although treatment with EVs DCs+Tp did not modify the proportion of total CD3+ T cells during the infection (Figure 4E, left panel; EVs DCs versus EVs DCs+Tp treated), EVs DCs+Tp treatment enhanced the percentage of CD8+T cells (Figure 4E, right panel). The gene discussed is CD8A; the disease is infection.